XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.2
SHARE CAPITAL (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Oct. 25, 2023
Jun. 28, 2023
Jun. 26, 2023
Jun. 16, 2023
Jun. 02, 2023
May 23, 2023
May 22, 2023
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2023
Feb. 13, 2023
Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Common stock, shares issued               11,707,317   11,707,317   7,890,628
Common stock, shares outstanding               11,707,317   11,707,317   7,890,628
Class of warrant or right, outstanding                     240,000  
Exercise price                     $ 0.0001  
Modifications amount                   $ 1,230    
Series B Preferred Investment Options [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Expiry date Oct. 25, 2027                      
Options exercise price per share $ 2.20                      
Common Stock [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Aggregate shares of common stock               3,576,689 [1] 240,000      
Common Stock [Member] | Series B Preferred Investment Options [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Cashless exercise of shares       385,246                
Common Stock [Member] | Private Placement [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Gross proceeds     $ 2,030,000   $ 1,500,000 $ 2,661,000 $ 1,442,000          
Offering expenses     $ 281,000   $ 227,000 $ 345,000 $ 222,000          
Common Stock [Member] | Series D Preferred Investment Options [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Aggregate shares of common stock   312,309         32,778          
Share price per share   $ 3.19       $ 2.1999            
Common Stock [Member] | Series C Preferred Investment Options [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Aggregate shares of common stock         350,878              
Share price per share         $ 2.075              
Common Stock [Member] | Series A Preferred Investment Options [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Aggregate shares of common stock                   1,022,495    
Share price per share               $ 4.64   $ 4.64    
Expiry date                   Oct. 25, 2027    
Common Stock [Member] | Series B Preferred Investment Options [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Aggregate shares of common stock                   1,022,495    
Share price per share               $ 4.64   $ 4.64    
Expiry date                   Oct. 25, 2024    
Securities Purchase Agreement [Member] | Common Stock [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Aggregate shares of common stock     624,618   701,756 975,000 655,569          
Share price per share     $ 3.25   $ 2.1375 $ 2.20 $ 2.20          
Prefunded warrants exercisable           234,500            
Securities Purchase Agreement [Member] | Common Stock [Member] | Wainwright [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Aggregate shares of common stock           60,476            
Securities Purchase Agreement [Member] | Common Stock [Member] | H.C. Wainwright & Co. LLC [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Aggregate shares of common stock     31,231                  
Director [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross                   85,000    
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price                   $ 3.07    
[1] Net of issuance costs in the amount of $1,075, of which $160 had not been paid as of June 30, 2023. See also Note 5.